Exane Derivatives Cerence Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Cerence Inc. stock. As of the latest transaction made, Exane Derivatives holds 31 shares of CRNC stock, worth $259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31
Previous 1,550
98.0%
Holding current value
$259
Previous $55,000
100.0%
% of portfolio
0.0%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding CRNC
# of Institutions
224Shares Held
30.2MCall Options Held
1.22MPut Options Held
1.12M-
Vanguard Group Inc Valley Forge, PA3.46MShares$28.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$27.6 Million0.0% of portfolio
-
American Capital Management Inc New York, NY2.68MShares$22.4 Million1.34% of portfolio
-
Paradigm Capital Management Inc2.04MShares$17.1 Million1.13% of portfolio
-
Connor, Clark & Lunn Investment Management Ltd.1.48MShares$12.3 Million0.06% of portfolio
About Cerence Inc.
- Ticker CRNC
- Exchange NASDAQ
- Sector Technology
- Industry Software—Application
- Shares Outstandng 39,313,000
- Market Cap $329M
- Description
- Cerence Inc. provides AI powered virtual assistants for the mobility/transportation market worldwide. The company offers edge software components; cloud-connected components and related toolkits and applications; and virtual assistant coexistence and professional services. It also provides conversational artificial intelligence-based solutions, ...